Increased oxidative stress in patients with essential thrombocythemia

dc.authorid0000-0002-7487-4603
dc.authorid0000-0001-7539-8066
dc.authorid0000-0002-9617-6689
dc.contributor.authorDurmus, A.
dc.contributor.authorMentese, A.
dc.contributor.authorYilmaz, M.
dc.contributor.authorSumer, A.
dc.contributor.authorAkalin, I.
dc.contributor.authorTopal, C.
dc.contributor.authorAlver, A.
dc.date.accessioned2025-05-10T19:28:39Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBACKGROUND: Essential thrombocythemia (ET) is a clonal disease in which thrombotic and hemorrhagic complications are common. Our aim in this study was to investigate whether oxidative stress in ET patients increased compared to healthy volunteers and to investigate whether there is a relationship between vascular events and oxidative status parameters in ET patients. PATIENTS AND METHODS: We determined the serum levels of oxidative status parameters, such as total oxidative status (TOS), total antioxidant status (TAS), oxidative stress index (OSI) and malondialdehyde (MDA) in ET patients. Forty-three ET patients (20 males, 23 females) and 20 healthy volunteers were enrolled. Oxidative status parameters of the patients were compared with those of the controls at time of diagnosis and at 6th-month follow-up. Additionally, oxidative status parameters of patients with ET with a history of vascular event were compared with patients without a vascular event history during diagnosis. RESULTS: Rises in TOS, OSI, and MDA were statistically significant in the patients group; however, the TAS value was significantly lower compared to the control group. Furthermore, TOS was significantly higher in patients with history of vascular event compared to the patients without such a history. Following therapy, OSI and MDA values were significantly reduced in the patient group compared to the pre-treatment values. CONCLUSIONS: Our findings reveal that although oxidative stress parameters were increased, compensative total antioxidant status was significantly reduced in ET patients. Furthermore, TOS values were significantly high in patients with a history of vascular event.
dc.identifier.endpage2866
dc.identifier.issn1128-3602
dc.identifier.issue21
dc.identifier.pmid24254553
dc.identifier.scopusqualityQ2
dc.identifier.startpage2860
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7425
dc.identifier.volume17
dc.identifier.wosWOS:000328084800005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherVerduci Publisher
dc.relation.ispartofEuropean Review For Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectEssential thrombocythemia
dc.subjectVascular event
dc.subjectOxidative stress
dc.subjectAntioxidant status
dc.titleIncreased oxidative stress in patients with essential thrombocythemia
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
7425
Boyut:
144.69 KB
Biçim:
Adobe Portable Document Format